Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Aleniglipron

GSBR-1290

Gasherbrum Bio, Inc · Phase 2 · Completed · Enrollment 58

NCT07400588

ArmPopulationDoseWeeksEstimandWeight change
Arm 1: Participants will receive aleniglipron administered orallyObesity + T2Dn/rn/rn/rn/r
Arm 2: Participants will receive a placebo administered orallyObesity + T2Dn/rn/rn/rn/r